Title : Pharmacokinetics of asciminib in the presence of CYP3A or P-gp inhibitors, CYP3A inducers, and acid-reducing agents.

Pub. Date : 2022 May 26

PMID : 35616006






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Asciminib is a first-in-class inhibitor of BCR::ABL1, specifically targeting the ABL myristoyl pocket. asciminib ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens
2 Asciminib is a first-in-class inhibitor of BCR::ABL1, specifically targeting the ABL myristoyl pocket. asciminib ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens